Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms

Autor: Vladan P. Čokić, Olivera Mitrović-Ajtić, Bojana B. Beleslin-Čokić, Dragana Marković, Marijana Buač, Miloš Diklić, Nada Kraguljac-Kurtović, Svetozar Damjanović, Pavle Milenković, Mirjana Gotić, Puri K. Raj

Publikováno v: Mediators of Inflammation, Vol 2015 (2015)

The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling pathway related genes

Externí odkaz: https://doaj.org/article/4875d06e34dc42e5aa02a133763630c9

P281 Similarity in the neurotoxic action of some antiarrhythmic agents and 4-aminopyridine

Autor: Milica N. Dekleva, Bojana B. Beleslin-Čokić, B.B. Beleslin, Vladan P. Čokić

Publikováno v: Electroencephalography and Clinical Neurophysiology. 99:336

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f2f34fa13bcdbcf95a41bf470eb9bf5
https://doi.org/10.1016/0013-4694(96)88409-4

Sex Differences and Cytokine Profiles among Patients Hospitalized for COVID-19 and during Their Recovery: The Predominance of Adhesion Molecules in Females and Oxidative Stress in Males.

Autor: Mitrović-Ajtić O; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia., Đikić D; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia., Subotički T; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia., Bižić-Radulović S; Clinic of Hematology, University Clinical Center of Serbia, Dr. Koste Todorovica 2, 11000 Belgrade, Serbia., Beleslin-Čokić B; Clinic of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Dr. Subotica starijeg 13, 11000 Belgrade, Serbia., Dragojević T; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia., Živković E; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia., Miljatović S; Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Bulevar oslobođenja 16, 11000 Belgrade, Serbia., Vukotić M; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia., Stanisavljević D; Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Santibanez J; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia.; Centro Integrativo de Biología y Química Aplicada (CIBQA), Universidad Bernardo O'Higgins, Santiago 8370854, Chile., Čokić VP; Institute for Medical Research, University of Belgrade, National Institute of Republic of Serbia, Dr. Subotica starijeg 4, 11129 Belgrade, Serbia.

Publikováno v: Vaccines [Vaccines (Basel)] 2023 Oct 03; Vol. 11 (10). Date of Electronic Publication: 2023 Oct 03.

Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms.

Autor: Vukotić M; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Kapor S; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.; Department of Hematology, Clinical Hospital Centre Dragisa Mišović, Belgrade, Serbia., Dragojević T; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Đikić D; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Mitrović Ajtić O; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Diklić M; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Subotički T; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Živković E; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia., Beleslin Čokić B; Clinic for Endocrinology, Diabetes and Metabolic Diseases Genetic Laboratory, University Clinical Center of Serbia, Belgrade, Serbia., Vojvodić A; Department of Orthopedic Surgery, Clinical Center Zemun, Belgrade, Serbia., Santibáñez JF; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.; Centro Integrativo de Biología y Química Aplicada (CIBQA), Universidad Bernardo O'Higgins, Santiago, Chile., Gotić M; Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia., Čokić VP; Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia. vl@imi.bg.ac.rs.

Publikováno v: Experimental & molecular medicine [Exp Mol Med] 2022 Mar; Vol. 54 (3), pp. 273-284. Date of Electronic Publication: 2022 Mar 14.

IL6 inhibition of inflammatory S100A8/9 proteins is NF-κB mediated in essential thrombocythemia.

Autor: Diklić M; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Mitrović-Ajtić O; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Subotički T; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Djikić D; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Kovačić M; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Bjelica S; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Beleslin-Čokić B; Clinic for Endocrinology, Diabetes and Metabolic Diseases, Genetic Laboratory, Clinical Center of Serbia, Belgrade, Serbia., Tošić M; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Leković D; Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia.; School of Medicine, University of Belgrade, Belgrade, Serbia., Gotić M; Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia.; School of Medicine, University of Belgrade, Belgrade, Serbia., Santibanez JF; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia., Čokić VP; Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgade, Serbia.

Publikováno v: Cell biochemistry and function [Cell Biochem Funct] 2020 Jun; Vol. 38 (4), pp. 362-372. Date of Electronic Publication: 2019 Dec 29.